Glenn Beck: Why are the FDA & Pfizer REFUSING to release vaccine data?



Civil rights attorney Aaron Siri is demanding answers and transparency from Pfizer. He represents dozens of doctors and medial professionals, from the nation’s most prestigious institutions, who all wish to conduct a critical review of the vaccine but are unable to thanks to Pfizer and the FDA. Siri joined Glenn Beck on the radio program to explain why this lawsuit is so important for all Americans.

According to Siri, the FDA has claimed it will take over 75 years for Pfizer to review and release the documents in question, even though it only took them only 108 days to do the same before approving the vaccine for public use.

"It's the FDA — the taxpayer-funded agency that's supposed to be looking out for our interests — that is refusing to release the data," Siri told Glenn. "The FDA reviewed those same documents, in a review they said was thorough and complete and robust, in just 108 days to license Pfizer's COVID-19 vaccine product for use in America.

"But yet, when it comes to being transparent with the documents reviewed, the documents received from Pfizer, [the FDA] is saying that it will only produce about 500 pages a month. So with over 450,000 pages, what that means is that the documents won't be fully produced until the year, at least, 2096 ... that makes a joke of the FDA and the federal government's promise of transparency."

Siri went on to note that the federal government has given FISA complete immunity from liability for any injuries caused by the product they are seeking to mandate for all Americans.

"You're an American, you get this product, and you're injured. The federal government does not let you sue them or anybody else. You're basically on your own," Siri explained. "The federal government is also mandating you to take this product. And, the federal government has given Pfizer over $17 billion. But yet, the federal government doesn't want to let you see the documents," he continued.

"At a minimum, Americans should be given the dignity, if they have to take it and they can't sue for harm, at least they should have the ability to get a second opinion. An independent review. We call it peer review in science," Siri added. "Absolutely, it's very concerning. But I think it's the result of what happens when government steps in and acts, really like a company, instead of working for the people."

Watch the video clip below to catch more if this important conversation:


Want more from Glenn Beck?

To enjoy more of Glenn’s masterful storytelling, thought-provoking analysis, and uncanny ability to make sense of the chaos, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

Top vaccine officials leave FDA amid infighting, political pressure — now there are warnings of a 'mutiny'



A pair of top vaccine regulators at the U.S. Food and Drug Administration resigned this week reportedly as a result of growing turmoil and disagreement within the agency as political pressures reportedly complicate the administration's scientific work.

What happened?

Dr. Marion Gruber, director of the FDA's Office of Vaccines Research and Review, and her deputy, Philip Krause, announced their intentions to leave the FDA with little fanfare on Tuesday. In a memo sent to news publishers, the FDA framed the decision as a simple retirement, thanking Gruber and Krause for their service but offering no reason for their forthcoming departure.

It seemed peculiar that two key vaccine officials would "retire" from the agency in the middle of a global pandemic and at a time when their expertise was most needed. Gruber, a veteran vaccine regulator, had been with the FDA for 32 years.

Sure enough, there was more bubbling under the surface.

In a report published Tuesday evening, Politico indicated the pair's departure was the result of increasing frustration over the Biden administration's top-down approach to managing the pandemic, specifically as it pertains to administering booster shots for adults:

FDA officials are scrambling to collect and analyze data that clearly demonstrate the boosters' benefits before the administration's Sept. 20 deadline for rolling them out to most adults ...

... On Tuesday, two top FDA vaccine regulators resigned — a decision that one former official said was rooted in anger over the agency's lack of autonomy in the booster planning so far. A current health official said the pair, Marion Gruber and Philip Krause, left over differences with FDA's top vaccine official Peter Marks. Now the agency is facing a potential mutiny among its staff and outside vaccine advisers, several of whom feel cut out of key decisions and who view the plan to offer boosters to all adults as premature and unnecessary.

POLITICO spoke to 11 current and former health officials and people familiar with the matter who described growing exasperation with the administration's disjointed process for implementing its booster plan. Those sources said there is little coordination between federal health agencies, even as two top FDA officials try to guide the rollout.

The news outlet characterized Gruber and Krause's exit as a symptom of a greater problem brewing within the FDA, even warning that a potential "mutiny" could be just around the corner.

What else?

Paul Offit, an infectious disease expert at the University of Pennsylvania who sits on FDA's vaccine advisory committee, shared a similar sentiment, claiming the administration has pushed ahead on boosters without allowing FDA scientists to meaningfully weigh in.

"[It was] the administration's booster plan; it wasn't the FDA's booster plan," Offit told Politico. "The administration has kind of backed themselves up against the wall a little bit here."

Moreover, disagreement over vaccine boosters may not be the only hot-button topic causing discord within the agency. The Hill reported on Monday that FDA regulators are facing "growing pressure to authorize vaccines for children under 12," something the agency has so far been reluctant to do.